Natera, Inc.

NTRA

Natera, Inc.

NTRA

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-24Shares Purchased (TTM):0Shares Sold (TTM):943,714

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:100,612,893Shares Outstanding:141,502,000Institutional Ownership Pct.:71.10%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Medical Laboratories

DGX LH GH CELC CAI RDNT

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,088	1,076	1,041	1,000	974	946	893	797	814	642	669	381
Marketable Securities Current	-	-	1	16	18	23	29	90	69	237	268	355
Accounts Receivable Net Current	418	297	286	309	318	314	307	336	289	278	255	260
Inventory Net	71	68	65	54	50	45	49	41	43	41	42	43
Prepaid Expense And Other Assets Current	76	56	54	52	56	49	45	38	47	61	33	27
Assets Current	1,652	1,497	1,447	1,432	1,416	1,376	1,323	1,302	1,261	1,259	1,267	1,066
Property Plant And Equipment Net	269	241	206	189	180	162	142	133	126	111	105	103
Operating Lease Right Of Use Asset	134	109	97	95	95	86	88	53	55	57	58	62
Goodwill	141	141	-	-	-	-	-	-	-	-	-	-
Intangible Assets Net Excluding Goodwill	367	374	-	-	-	11	-	-	-	-	-	-
Other Assets Noncurrent	51	37	71	41	41	26	38	29	26	15	16	18
Assets	2,614	2,398	1,821	1,757	1,732	1,661	1,591	1,517	1,468	1,442	1,447	1,248
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	62	33	46	37	39	35	28	33	26	15	21	21
Employee Related Liabilities Current	144	93	77	55	47	62	49	41	40	46	39	34
Business Combination Contingent Consideration Liab…	22	22	-	-	-	-	-	-	-	-	-	-
Contract With Customer Liability Current	37	25	22	22	21	20	18	18	18	17	15	16
Short Term Borrowings	80	80	80	80	80	80	80	80	80	80	80	80
Other Liabilities Current	213	189	216	191	178	147	126	141	142	149	134	126
Liabilities Current	558	441	442	385	366	344	301	315	306	307	290	277
Long Term Notes And Loans	-	-	-	-	-	-	287	284	283	283	283	282
Business Combination Contingent Consideration Liab…	103	97	-	-	-	-	-	-	-	-	-	-
Deferred Tax And Other Liabilities Noncurrent	1	1	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	145	118	104	103	103	97	99	61	64	67	68	71
Contract With Customer Liability Noncurrent	17	17	-	-	-	17	-	-	-	19	21	22
Other Liabilities Noncurrent	16	12	-	-	-	8	-	-	-	-	-	-
Liabilities	840	686	569	511	493	465	712	680	674	676	662	652
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	4,635	4,489	4,076	3,982	3,875	3,764	3,393	3,320	3,241	3,146	3,089	2,796
Retained Earnings Accumulated Deficit	-2,861	-2,776	-2,823	-2,736	-2,635	-2,568	-2,514	-2,482	-2,445	-2,377	-2,299	-2,190
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-1	-1	-2	-3	-5	-9
Stockholders Equity	1,774	1,712	1,252	1,246	1,240	1,195	879	837	794	765	785	596
Liabilities And Stockholders Equity	2,614	2,398	1,821	1,757	1,732	1,661	1,591	1,517	1,468	1,442	1,447	1,248
Allowance For Doubtful Accounts Receivable Current	8	8	8	8	7	7	6	7	7	6	6	6
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	750	750	750	750	750	750	750	750	750	750	750	750
Common Stock Shares Issued	143	140	138	137	136	133	124	123	122	120	119	114
Shares Outstanding	143	140	138	137	136	133	124	123	122	120	119	114

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	15.00%	34.84%	34.88%	-	-	-	-	-	-	-	-	-
2025	3.80%	10.54%	-8.59%	10.73%	7.25%	26.69%	19.66%	17.12%	21.05%	-6.13%	0.17%	-10.42%
2024	1.18%	2.85%	-2.49%	3.22%	9.73%	2.71%	27.04%	24.04%	30.94%	-2.85%	-4.83%	-1.93%
2023	-4.69%	-4.98%	-10.41%	12.47%	-10.19%	-20.11%	28.79%	38.00%	44.17%	6.74%	-1.40%	23.09%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.96	3.39	3.27	3.72	3.87	4.00	4.39	4.14	4.12	4.10	4.37	3.85
Quick Ratio	2.70	3.11	3.01	3.44	3.58	3.73	4.08	3.89	3.83	3.77	4.11	3.60
Working Capital	1.09B	1.06B	1.01B	1.05B	1.05B	1.03B	1.02B	987.24M	955.50M	951.28M	977.35M	788.66M
Leverage & Debt
Debt to Equity	0.47	0.40	0.45	0.41	0.40	0.39	0.81	0.81	0.85	0.88	0.84	1.09
Interest Coverage TTM	-81.96	-76.16	-80.50	-45.40	-26.52	-20.80	-19.30	-24.80	-30.10	-35.31	-41.13	-45.19
Debt Ratio	0.32	0.29	0.31	0.29	0.28	0.28	0.45	0.45	0.46	0.47	0.46	0.52
Efficiency & Turnover
Asset Turnover TTM	1.15	1.14	1.24	1.20	1.14	1.09	1.01	0.98	0.87	0.76	0.81	0.80
Days Sales Outstanding TTM	53.70	48.33	51.15	59.94	60.50	63.72	66.95	79.95	80.87	88.11	90.72	91.81
Receivables Turnover TTM	6.80	7.55	7.14	6.09	6.03	5.73	5.45	4.57	4.51	4.14	4.02	3.98
Per Share Metrics
Diluted EPS TTM	-1.60	-1.52	-2.25	-1.86	-1.41	-1.53	-1.73	-2.38	-3.03	-3.78	-4.34	-4.50
Free Cash Flow Per Share TTM	0.74	0.80	0.77	0.77	0.63	0.56	-0.27	-0.87	-1.55	-2.49	-2.70	-3.41
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	95.39%	97.63%	73.15%	73.08%	61.87%	60.38%	86.46%	86.27%	86.78%	99.88%	103.45%	107.05%
Operating Profit Margin TTM	-12.97%	-13.44%	-16.62%	-14.95%	-12.41%	-13.10%	-15.80%	-23.06%	-31.63%	-41.22%	-50.92%	-54.94%
Net Profit Margin TTM	-9.05%	-9.03%	-14.61%	-12.89%	-10.36%	-11.22%	-14.01%	-21.47%	-30.24%	-40.16%	-50.50%	-54.97%
Growth Metrics
Net Revenue Growth (1Y)	36.59%	35.90%	38.17%	44.38%	51.50%	56.75%	54.94%	46.13%	39.26%	31.99%	27.41%	28.69%
Net Income Growth (1Y)	19.26%	9.31%	44.02%	-13.31%	-48.08%	-56.20%	-57.01%	-42.92%	-33.08%	-20.63%	-8.51%	-11.08%
EPS Growth (1Y)	13.57%	-0.28%	29.94%	-21.91%	-53.45%	-59.62%	-59.99%	-47.18%	-38.09%	-32.08%	-22.90%	-24.47%
Valuation Metrics
P/E TTM	-125.04	-150.47	-71.42	-90.99	-100.41	-103.68	-73.19	-45.54	-30.23	-16.57	-10.21	-10.81
P/B TTM	15.95	18.29	17.64	18.49	15.37	16.52	17.89	15.90	13.91	9.41	6.49	9.28
P/S TTM	11.32	13.58	10.43	11.73	10.41	11.63	10.26	9.78	9.14	6.65	5.15	5.94
Market Cap	28.30B	31.32B	22.08B	23.04B	19.05B	19.74B	15.71B	13.30B	11.05B	7.20B	5.10B	5.53B
Enterprise Value	27.29B	30.33B	21.12B	22.12B	18.16B	18.88B	14.90B	12.59B	10.32B	6.64B	4.51B	5.23B
Calculated Values
Free Cash Flow TTM	104.51M	109.11M	106.07M	104.56M	85.19M	69.24M	-33.19M	-107.32M	-186.98M	-286.15M	-311.45M	-387.25M
Net Debt	-1.01B	-995.82M	-961.10M	-919.68M	-893.42M	-865.23M	-812.38M	-716.41M	-733.42M	-561.69M	-588.28M	-300.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-24Sale

Owner: Rosenman, Herm

Title: -

Shares: 16,530

Price/Share: $250.00

Value: $4,132,500.00

Shares Owned: 4,250

Relationship: Director

Ownership: Direct

2026-06-24Sale

Owner: Rabinowitz, Daniel

Title: SEC. AND CHIEF LEGAL OFFICER

Shares: 33,600

Price/Share: $251.89

Value: $8,463,504.00

Shares Owned: 189,094

Relationship: Officer

Ownership: Direct

2026-06-17Sale

Owner: Sheena, Jonathan

Title: -

Shares: 1,500

Price/Share: $220.12

Value: $330,180.00

Shares Owned: 18,782

Relationship: Director,Other

Ownership: Indirect

2026-06-16Sale

Owner: Chapman, Rowan E

Title: -

Shares: 2,964

Price/Share: $216.78

Value: $642,535.92

Shares Owned: 3,124

Relationship: Director

Ownership: Direct

2026-06-15Sale

Owner: Sheena, Jonathan

Title: -

Shares: 3,150

Price/Share: $211.90

Value: $667,485.00

Shares Owned: 249,352

Relationship: Director,Other

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-24	Rosenman, Herm	Director	-	Direct	Sale	16,530	250.00	$4,132,500.00	4,250	4
2026-06-24	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	33,600	251.89	$8,463,504.00	189,094	4
2026-06-17	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	220.12	$330,180.00	18,782	4
2026-06-16	Chapman, Rowan E	Director	-	Direct	Sale	2,964	216.78	$642,535.92	3,124	4
2026-06-15	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,150	211.90	$667,485.00	249,352	4
2026-06-15	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	50,000	214.28	$10,714,000.00	2,277,843	4
2026-06-05	Marcus, Gail Boxer	Director	-	Direct	Sale	11,000	217.57	$2,393,270.00	6,183	4
2026-06-04	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	41,124	219.93	$9,044,401.32	108,743	4
2026-06-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	219.09	$657,270.00	137,643	4
2026-06-01	Botha, Roelof	Director	-	Indirect	Sale	78,000	221.27	$17,259,060.00	1,076,198	4
2026-05-26	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,652	202.84	$335,091.68	140,643	4
2026-05-26	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,438	202.84	$291,683.92	185,782	4
2026-05-13	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	201.58	$302,370.00	19,532	4
2026-05-05	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	6,986	215.04	$1,502,269.44	2,376,402	4
2026-05-04	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	482	210.49	$101,456.18	57,496	4
2026-05-01	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	291	206.16	$59,992.56	187,220	4
2026-05-01	Sheena, Jonathan	Director,Other	-	Direct	Sale	107	206.16	$22,059.12	255,652	4
2026-05-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,405	204.11	$694,994.55	142,295	4
2026-05-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	902	206.16	$185,956.32	149,867	4
2026-05-01	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	330	206.16	$68,032.80	222,694	4
2026-04-29	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,071	196.60	$603,758.60	255,711	4
2026-04-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,070	193.62	$594,413.40	58,291	4
2026-04-27	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,838	204.07	$1,191,360.66	150,769	4
2026-04-27	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,182	204.07	$445,280.74	145,700	4
2026-04-27	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,861	204.07	$379,774.27	223,024	4
2026-04-27	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,688	204.07	$344,470.16	187,511	4
2026-04-17	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	199.62	$299,430.00	20,282	4
2026-04-01	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	8,400	202.94	$1,704,696.00	224,885	4
2026-04-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	202.33	$606,990.00	147,882	4
2026-03-20	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	199.82	$299,730.00	21,032	4
2026-03-16	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	50,000	194.28	$9,714,000.00	2,310,772	4
2026-03-13	Chapman, Rowan E	Director	-	Direct	Sale	122	191.38	$23,348.36	5,752	4
2026-03-10	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,623	204.13	$1,147,822.99	156,607	4
2026-03-10	Sheena, Jonathan	Director,Other	-	Direct	Sale	127	204.13	$25,924.51	262,325	4
2026-03-10	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	915	204.13	$186,778.95	150,882	4
2026-03-10	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	785	204.13	$160,242.05	63,354	4
2026-03-10	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	707	204.13	$144,319.91	189,199	4
2026-03-10	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,745	204.13	$356,206.85	233,285	4
2026-03-06	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	8,398	195.86	$1,644,832.28	233,285	4
2026-03-02	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,070	200.74	$616,271.80	262,194	4
2026-03-02	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	3,950	200.20	$790,790.00	156,607	4
2026-03-02	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	199.97	$599,910.00	150,023	4
2026-02-03	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	3,594	230.96	$830,070.24	178,081	4
2026-02-03	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,639	230.77	$378,232.03	137,847	4
2026-02-03	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,334	230.77	$307,847.18	223,813	4
2026-02-03	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	6,939	227.82	$1,580,842.98	52,120	4
2026-02-03	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,725	230.77	$1,090,388.25	123,156	4
2026-02-03	Sheena, Jonathan	Director,Other	-	Direct	Sale	435	230.77	$100,384.95	263,161	4
2026-01-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,867	230.43	$430,212.81	59,059	4
2026-01-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	928	237.66	$220,548.48	175,540	4
2026-01-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,000	237.66	$237,660.00	225,147	4
2026-01-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,200	237.66	$285,192.00	142,486	4
2026-01-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	191	237.66	$45,393.06	263,596	4
2026-01-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	3,648	237.66	$866,983.68	213,180	4
2026-01-23	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	243.84	$365,760.00	21,782	4
2026-01-21	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	293	235.00	$68,855.00	144,699	4
2026-01-21	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	37,175	238.83	$8,878,505.25	64,123	4
2026-01-21	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	438	235.00	$102,930.00	227,033	4
2026-01-21	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	1,590	235.00	$373,650.00	219,150	4
2026-01-21	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	339	235.00	$79,665.00	177,252	4
2026-01-21	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,163	234.98	$743,241.74	264,078	4
2026-01-02	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,951	228.88	$675,424.88	123,499	4
2026-01-02	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	3,848	229.15	$881,769.20	136,568	4
2025-12-19	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	225.58	$338,370.00	22,532	4
2025-12-17	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,070	227.42	$698,179.40	222,966	4
2025-12-12	Rosenman, Herm	Director	-	Direct	Sale	48,419	227.89	$11,034,205.91	20,342	4
2025-12-12	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	4,692	230.76	$1,082,725.92	113,065	4
2025-12-05	Chapman, Rowan E	Director	-	Direct	Sale	4,366	243.24	$1,061,985.84	5,777	4
2025-12-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	238.19	$714,570.00	109,061	4
2025-12-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,400	238.21	$1,048,124.00	140,416	4
2025-11-24	Botha, Roelof	Director	-	Indirect	Sale	75,000	234.43	$17,582,250.00	1,154,198	4
2025-11-21	Sheena, Jonathan	Director,Other	-	Indirect	Sale	4,000	230.01	$920,040.00	23,282	4
2025-11-20	Baynes, Roy D.	Director	-	Direct	Sale	7,668	222.73	$1,707,893.64	18,359	4
2025-11-11	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	208.03	$312,045.00	25,282	4
2025-11-04	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	22,900	200.74	$4,596,946.00	2,280,852	4
2025-11-03	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	17,100	200.00	$3,420,000.00	2,303,752	4
2025-11-03	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	160,703	199.00	$31,979,897.00	144,816	4
2025-11-03	Sheena, Jonathan	Director,Other	-	Indirect	Sale	4,000	200.07	$800,280.00	26,032	4
2025-11-03	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	198.96	$596,880.00	112,061	4
2025-11-03	Marcus, Gail Boxer	Director	-	Direct	Sale	122	198.71	$24,242.62	5,762	4
2025-10-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,867	190.35	$355,383.45	64,126	4
2025-10-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,198	191.46	$229,369.08	115,061	4
2025-10-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	3,680	191.46	$704,572.80	149,840	4
2025-10-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	928	191.46	$177,674.88	150,699	4
2025-10-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,058	191.46	$202,564.68	201,699	4
2025-10-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	191	191.46	$36,568.86	235,730	4
2025-10-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	755	196.77	$148,561.35	69,189	4
2025-10-21	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	602	187.95	$113,145.90	70,109	4
2025-10-21	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	464	187.95	$87,208.80	203,692	4
2025-10-21	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	1,603	187.95	$301,283.85	155,855	4
2025-10-21	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	292	187.95	$54,881.40	117,267	4
2025-10-21	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	339	187.95	$63,715.05	152,408	4
2025-10-21	Sheena, Jonathan	Director,Other	-	Direct	Sale	93	187.95	$17,479.35	236,209	4
2025-10-20	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	10,000	190.00	$1,900,000.00	5,000	4
2025-10-17	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,500	178.97	$268,455.00	28,032	4
2025-10-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	14,083	160.15	$2,255,392.45	154,072	4
2025-10-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	159.86	$479,580.00	117,559	4
2025-09-30	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,491	162.05	$403,666.55	69,189	4
2025-09-30	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,364	162.05	$221,036.20	203,300	4
2025-09-19	Sheena, Jonathan	Director,Other	-	Indirect	Sale	11,000	179.91	$1,979,010.00	28,782	4
2025-09-19	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	25,527	180.91	$4,618,089.57	2,320,852	4
2025-09-12	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	5,000	171.48	$857,400.00	25,000	4
2025-09-02	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,079	166.47	$845,501.13	158,514	4
2025-09-02	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	166.60	$499,800.00	120,859	4
2025-08-28	Chapman, Rowan E	Director	-	Direct	Sale	2,750	166.99	$459,222.50	6,015	4
2025-08-14	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	678	155.38	$105,347.64	152,747	4
2025-08-14	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	875	155.44	$136,010.00	123,859	4
2025-08-11	Sheena, Jonathan	Director,Other	-	Indirect	Sale	3,000	153.33	$459,990.00	34,282	4
2025-08-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,807	132.87	$771,576.09	163,593	4
2025-08-01	Marcus, Gail Boxer	Director	-	Direct	Sale	2,496	133.20	$332,467.20	5,763	4
2025-08-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	133.28	$399,840.00	123,059	4
2025-07-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,045	137.15	$417,621.75	65,430	4
2025-07-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,994	139.81	$278,781.14	202,164	4
2025-07-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	479	139.81	$66,968.99	245,322	4
2025-07-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,206	139.81	$308,420.86	126,059	4
2025-07-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,710	139.81	$239,075.10	151,750	4
2025-07-28	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	1,718	139.81	$240,193.58	2,360,852	4
2025-07-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,092	139.81	$851,722.52	169,400	4
2025-07-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	755	139.57	$105,375.35	70,494	4
2025-07-21	Sheena, Jonathan	Director,Other	-	Direct	Sale	93	139.29	$12,953.97	245,801	4
2025-07-21	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	339	139.29	$47,219.31	153,460	4
2025-07-21	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	464	139.29	$64,630.56	204,158	4
2025-07-21	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	602	139.29	$83,852.58	71,414	4
2025-07-21	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	1,622	139.29	$225,928.38	175,492	4
2025-07-21	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	291	139.29	$40,533.39	128,265	4
2025-07-16	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,070	149.96	$460,377.20	245,704	4
2025-07-02	Sheena, Jonathan	Director,Other	-	Indirect	Sale	3,000	160.18	$480,540.00	35,782	4
2025-07-01	Marcus, Gail Boxer	Director	-	Direct	Sale	4,299	167.30	$719,222.70	8,118	4
2025-07-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	166.23	$498,690.00	130,205	4
2025-07-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,343	166.20	$888,006.60	173,728	4
2025-06-18	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,070	167.29	$513,580.30	248,774	4
2025-06-13	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	5,000	165.85	$829,250.00	30,000	4
2025-06-10	Marcus, Gail Boxer	Director	-	Direct	Sale	4,000	164.69	$658,760.00	5,704	4
2025-06-02	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	157.76	$473,280.00	133,205	4
2025-06-02	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,111	157.14	$960,282.54	179,071	4
2025-05-12	Sheena, Jonathan	Director,Other	-	Indirect	Sale	3,000	158.24	$474,720.00	38,782	4
2025-05-01	Marcus, Gail Boxer	Director	-	Direct	Sale	4,000	149.99	$599,960.00	9,704	4
2025-05-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	150.40	$451,200.00	136,205	4
2025-05-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,980	150.37	$1,049,582.60	185,182	4
2025-04-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,045	154.26	$469,721.70	70,494	4
2025-04-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,709	152.18	$260,075.62	155,237	4
2025-04-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,993	152.18	$303,294.74	223,674	4
2025-04-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	439	152.18	$66,807.02	254,914	4
2025-04-28	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	1,718	152.18	$261,445.24	2,362,570	4
2025-04-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,206	152.18	$335,709.08	139,280	4
2025-04-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,203	152.18	$943,972.54	192,162	4
2025-04-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	755	152.45	$115,099.75	75,557	4
2025-04-21	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	296	146.20	$43,275.20	141,486	4
2025-04-21	Sheena, Jonathan	Director,Other	-	Direct	Sale	86	145.85	$12,543.10	255,353	4
2025-04-21	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	343	145.82	$50,016.26	156,946	4
2025-04-21	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	610	145.85	$88,968.50	76,468	4
2025-04-21	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	470	145.85	$68,549.50	225,667	4
2025-04-21	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	1,664	145.80	$242,611.20	198,365	4
2025-04-04	Sheena, Jonathan	Director,Other	-	Direct	Sale	3,070	134.09	$411,656.30	255,249	4
2025-04-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	15,898	140.74	$2,237,484.52	196,643	4
2025-04-01	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,000	140.79	$422,370.00	141,782	4
2025-04-01	Marcus, Gail Boxer	Director	-	Direct	Sale	4,000	141.14	$564,560.00	9,704	4
2025-03-31	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,404	138.40	$194,313.60	225,281	4
2025-03-31	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,562	138.38	$354,529.56	75,557	4
2025-03-18	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	145.86	$393,822.00	258,319	4
2025-03-17	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,026	147.88	$151,724.88	144,782	4
2025-03-17	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	1,127	147.80	$166,570.60	2,364,288	4
2025-03-17	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	795	147.80	$117,501.00	157,289	4
2025-03-17	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,702	146.03	$978,693.06	203,354	4
2025-03-17	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	792	147.80	$117,057.60	71,869	4
2025-03-17	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	928	147.88	$137,232.64	224,185	4
2025-03-14	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	50,000	147.39	$7,369,500.00	2,365,415	4
2025-03-12	Marcus, Gail Boxer	Director	-	Direct	Sale	4,000	147.76	$591,040.00	9,704	4
2025-03-05	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	6,000	143.56	$861,360.00	143,768	4
2025-03-05	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	87,272	143.78	$12,547,968.16	203,354	4
2025-02-26	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	159.19	$429,813.00	260,789	4
2025-02-06	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	663	177.77	$117,861.51	156,044	4
2025-02-06	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,632	177.77	$290,120.64	149,768	4
2025-02-03	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	43,502	176.86	$7,693,763.72	70,629	4
2025-01-31	Sheena, Jonathan	Director,Other	-	Direct	Sale	163	176.60	$28,785.80	259,940	4
2025-01-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	4,335	166.48	$721,690.80	103,697	4
2025-01-29	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	4,773	166.31	$793,797.63	213,020	4
2025-01-29	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	13,685	166.61	$2,280,057.85	253,944	4
2025-01-29	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	6,003	166.62	$1,000,219.86	2,383,177	4
2025-01-29	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	5,201	166.37	$865,290.37	135,483	4
2025-01-29	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	4,030	166.38	$670,511.40	143,200	4
2025-01-27	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,442	161.87	$233,416.54	108,032	4
2025-01-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	946	172.12	$162,825.52	109,474	4
2025-01-22	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	25,931	168.45	$4,368,076.95	109,665	4
2025-01-22	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	22,039	168.45	$3,712,469.55	217,793	4
2025-01-22	Sheena, Jonathan	Director,Other	-	Direct	Sale	971	168.43	$163,545.53	261,745	4
2025-01-22	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	21,228	168.46	$3,576,068.88	147,230	4
2025-01-22	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	78,553	168.46	$13,233,038.38	267,629	4
2025-01-22	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	24,861	168.45	$4,187,835.45	140,684	4
2025-01-08	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	6,223	175.30	$1,090,891.90	199,804	4
2025-01-02	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	159.68	$431,136.00	254,372	4
2024-12-23	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	669	158.77	$106,217.13	114,142	4
2024-12-23	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,428	158.62	$385,129.36	116,997	4
2024-12-18	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	167.12	$451,224.00	257,072	4
2024-12-13	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	160,000	166.45	$26,632,000.00	2,389,180	4
2024-12-10	Chapman, Rowan E	Director	-	Direct	Sale	1,767	170.24	$300,814.08	6,202	4
2024-12-09	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	4,858	166.59	$809,294.22	114,912	4
2024-12-02	Botha, Roelof	Director	-	Indirect	Sale	87,473	168.70	$14,756,695.10	1,224,787	4
2024-11-26	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	2,000	164.35	$328,700.00	84,000	4
2024-11-19	Marcus, Gail Boxer	Director	-	Direct	Sale	9,682	160.18	$1,550,862.76	9,704	4
2024-11-15	Baynes, Roy D.	Director	-	Direct	Sale	37,230	146.96	$5,471,320.80	15,807	4
2024-11-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,728	147.14	$695,677.92	185,034	4
2024-11-14	Marcus, Gail Boxer	Director	-	Direct	Sale	2,212	159.14	$352,017.68	19,386	4
2024-11-13	Sheena, Jonathan	Director,Other	-	Direct	Sale	20,000	153.40	$3,068,000.00	259,772	4
2024-11-08	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	130.84	$353,268.00	279,772	4
2024-10-31	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,866	126.45	$235,955.70	68,851	4
2024-10-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	754	119.93	$90,427.22	70,717	4
2024-10-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,196	118.21	$141,379.16	110,695	4
2024-10-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	929	118.21	$109,817.09	113,136	4
2024-10-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	3,960	118.21	$468,111.60	189,762	4
2024-10-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,057	118.21	$124,947.97	206,027	4
2024-10-25	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	691	118.81	$82,097.71	72,709	4
2024-10-23	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	496	119.09	$59,068.64	74,314	4
2024-10-22	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	349	120.07	$41,904.43	207,084	4
2024-10-22	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	199	120.07	$23,893.93	114,065	4
2024-10-22	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	454	120.07	$54,511.78	73,560	4
2024-10-22	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	893	120.07	$107,222.51	193,722	4
2024-10-22	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	256	120.07	$30,737.92	111,891	4
2024-10-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,523	130.40	$589,799.20	191,163	4
2024-10-01	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	125.69	$339,363.00	282,041	4
2024-09-18	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	127.72	$344,844.00	284,741	4
2024-09-16	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,024	128.84	$647,292.16	195,686	4
2024-09-13	Chapman, Rowan E	Director	-	Direct	Sale	2,614	127.68	$333,755.52	7,969	4
2024-08-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,583	119.40	$666,610.20	200,710	4
2024-08-15	Sheena, Jonathan	Director,Other	-	Direct	Sale	12,000	121.01	$1,452,120.00	287,441	4
2024-08-13	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	3,956	116.67	$461,546.52	114,606	4
2024-08-12	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	114.42	$308,934.00	299,441	4
2024-07-31	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,866	99.65	$185,946.90	71,955	4
2024-07-29	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,196	102.77	$122,912.92	112,441	4
2024-07-29	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,057	102.77	$108,627.89	206,400	4
2024-07-29	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,084	102.77	$419,712.68	206,293	4
2024-07-29	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	929	102.77	$95,473.33	108,462	4
2024-07-26	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	751	102.18	$76,737.18	75,059	4
2024-07-23	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	499	107.40	$53,592.60	77,418	4
2024-07-22	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,638	105.16	$277,412.08	210,377	4
2024-07-22	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	549	105.16	$57,732.84	113,637	4
2024-07-22	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	815	105.16	$85,705.40	207,457	4
2024-07-22	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	549	105.16	$57,732.84	109,391	4
2024-07-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	5,496	111.92	$615,112.32	207,855	4
2024-07-01	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	108.98	$294,246.00	301,808	4
2024-07-01	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	2,723	108.37	$295,091.51	206,772	4
2024-07-01	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	4,983	108.37	$540,007.71	75,059	4
2024-07-01	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	37,500	108.59	$4,072,125.00	213,351	4
2024-06-18	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	109.66	$296,082.00	304,508	4
2024-06-17	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,105	111.59	$681,256.95	213,351	4
2024-05-30	Marcus, Gail Boxer	Director	-	Direct	Sale	2,000	110.17	$220,340.00	18,634	4
2024-05-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,438	109.96	$158,122.48	109,940	4
2024-05-28	Chapman, Rowan E	Director	-	Direct	Sale	4,856	109.09	$529,741.04	5,005	4
2024-05-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,647	109.96	$181,104.12	114,186	4
2024-05-23	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,000	108.44	$108,440.00	68,582	4
2024-05-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,779	107.09	$725,963.11	219,456	4
2024-05-10	Sheena, Jonathan	Director,Other	-	Direct	Sale	2,700	105.39	$284,553.00	319,061	4
2024-05-10	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	30,000	104.15	$3,124,500.00	204,495	4
2024-05-01	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,866	94.20	$175,777.20	67,542	4
2024-04-29	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	929	93.14	$86,527.06	110,748	4
2024-04-29	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	1,196	93.14	$111,395.44	115,833	4
2024-04-29	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	1,057	93.14	$98,448.98	204,495	4
2024-04-29	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,084	93.14	$380,383.76	226,235	4
2024-04-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,238	93.14	$115,307.32	69,408	4
2024-04-26	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	751	92.00	$69,092.00	70,646	4
2024-04-25	Sheena, Jonathan	Director,Other	-	Indirect	Sale	1,000	89.55	$89,550.00	69,082	4
2024-04-23	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,523	91.38	$139,171.74	73,039	4
2024-04-23	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	531	91.38	$48,522.78	117,029	4
2024-04-23	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	787	91.38	$71,916.06	205,552	4
2024-04-23	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,552	91.38	$233,201.76	230,319	4
2024-04-23	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	522	91.38	$47,700.36	111,677	4
2024-04-16	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	80,000	90.70	$7,256,000.00	117,560	4
2024-04-15	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	6,816	93.67	$638,454.72	227,710	4
2024-04-03	Sheena, Jonathan	Director,Other	-	Direct	Sale	26,700	92.49	$2,469,483.00	321,031	4
2024-04-02	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,378	92.62	$127,630.36	70,646	4
2024-03-28	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	464	90.42	$41,954.88	112,199	4
2024-03-28	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	914	90.42	$82,643.88	72,024	4
2024-03-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,662	90.42	$240,698.04	234,526	4
2024-03-28	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	707	90.42	$63,926.94	197,560	4
2024-03-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	447	90.28	$40,355.16	347,731	4
2024-03-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	743	90.42	$67,182.06	204,839	4
2024-03-06	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	88.79	$443,950.00	458,585	4
2024-03-05	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,826	88.37	$249,733.62	70,646	4
2024-03-05	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	1,838	87.87	$161,505.06	112,663	4
2024-03-05	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	2,160	88.37	$190,879.20	204,218	4
2024-03-05	Rabinowitz, Matthew	Director,Officer	EXECUTIVE CHAIRMAN	Direct	Sale	1,012	87.81	$88,863.72	1,075,648	4
2024-03-05	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	2,245	87.85	$197,223.25	198,267	4
2024-03-05	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	9,326	88.37	$824,138.62	246,957	4
2024-02-29	Sheena, Jonathan	Director,Other	-	Direct	Sale	10,000	87.24	$872,400.00	463,585	4
2024-02-29	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	20,526	87.34	$1,792,740.84	204,218	4
2024-02-16	Rosenman, Herm	Director	-	Direct	Sale	93,901	69.46	$6,522,363.46	61,685	4
2024-02-07	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	70.10	$350,500.00	473,585	4
2024-02-06	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	34,029	70.03	$2,383,050.87	70,646	4
2024-02-01	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	22,281	67.73	$1,509,092.13	70,646	4
2024-01-29	Moshkevich, Solomon	Officer	PRESIDENT, CLINICALDIAGNOSTICS	Direct	Sale	3,426	65.09	$222,998.34	194,977	4
2024-01-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,235	65.09	$210,566.15	92,927	4
2024-01-29	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	4,265	65.09	$277,608.85	204,218	4
2024-01-29	Fesko, John	Officer	PRESIDENT, CHIEF BUS. OFFICER	Direct	Sale	2,358	65.09	$153,482.22	108,494	4
2024-01-29	Sheena, Jonathan	Director,Other	-	Direct	Sale	546	65.09	$35,539.14	478,585	4
2024-01-29	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	14,813	65.09	$964,178.17	246,957	4
2024-01-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	944	67.00	$63,248.00	64,810	4
2024-01-23	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,202	66.26	$145,904.52	65,754	4
2024-01-22	Sheena, Jonathan	Director,Other	-	Direct	Sale	351	68.16	$23,924.16	469,726	4
2024-01-22	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	1,958	68.16	$133,457.28	175,550	4
2024-01-22	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	892	68.16	$60,798.72	181,050	4
2024-01-03	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	60.32	$301,600.00	469,743	4
2023-12-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,377	62.29	$85,773.33	64,810	4
2023-12-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	447	62.68	$28,017.96	474,743	4
2023-12-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,604	63.29	$164,807.16	172,348	4
2023-12-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	728	63.29	$46,075.12	180,442	4
2023-12-13	Healy, James	Director	-	Indirect	Sale	644,000	58.75	$37,835,000.00	0	4
2023-12-08	Marcus, Gail Boxer	Director	-	Direct	Sale	500	57.52	$28,760.00	20,146	4
2023-12-06	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	58.52	$292,600.00	474,743	4
2023-11-29	Chapman, Rowan E	Director	-	Direct	Sale	1,998	55.97	$111,828.06	9,373	4
2023-11-21	Marcus, Gail Boxer	Director	-	Direct	Sale	1,000	54.31	$54,310.00	20,646	4
2023-11-20	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,566	55.00	$141,130.00	217,554	4
2023-11-02	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	40.23	$201,150.00	479,743	4
2023-10-23	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	803	40.39	$32,433.17	179,807	4
2023-10-23	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,940	40.55	$159,767.00	64,810	4
2023-10-23	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,595	40.39	$104,812.05	220,120	4
2023-10-23	Sheena, Jonathan	Director,Other	-	Direct	Sale	335	40.25	$13,483.75	484,743	4
2023-09-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,372	45.98	$63,084.56	64,833	4
2023-09-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,617	45.82	$119,910.94	217,554	4
2023-09-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	732	45.82	$33,540.24	179,110	4
2023-09-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,448	45.94	$250,281.12	484,745	4
2023-09-06	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	59.31	$296,550.00	489,746	4
2023-09-01	Sheena, Jonathan	Director,Other	-	Direct	Sale	10,000	60.01	$600,100.00	494,746	4
2023-08-11	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,578	55.00	$141,790.00	214,988	4
2023-08-02	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,000	44.22	$221,100.00	504,746	4
2023-07-25	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,347	46.58	$109,323.26	64,833	4
2023-07-24	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,570	47.83	$75,093.10	67,180	4
2023-07-24	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	800	47.83	$38,264.00	178,478	4
2023-07-24	Sheena, Jonathan	Director,Other	-	Direct	Sale	100	47.82	$4,782.00	509,746	4
2023-07-24	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,578	47.83	$123,305.74	217,566	4
2023-06-29	Brophy, Michael Burkes	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,377	51.11	$70,378.47	64,833	4
2023-06-28	Chapman, Steven Leonard	Director,Officer	CEO AND PRESIDENT	Direct	Sale	2,605	50.88	$132,542.40	214,983	4
2023-06-28	Rabinowitz, Daniel	Officer	SEC. AND CHIEF LEGAL OFFICER	Direct	Sale	728	50.88	$37,040.64	177,778	4
2023-06-28	Sheena, Jonathan	Director,Other	-	Direct	Sale	5,447	50.86	$277,034.42	509,746	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

71.10%

Inst. Shares: 100,612,893

Shares Outstanding: 141,502,000

2025-12-31

83.53%

Inst. Shares: 114,206,686

Shares Outstanding: 136,721,000

2025-09-30

80.55%

Inst. Shares: 110,505,256

Shares Outstanding: 137,187,000

2025-06-30

82.05%

Inst. Shares: 111,907,817

Shares Outstanding: 136,388,000

2025-03-31

81.55%

Inst. Shares: 109,886,322

Shares Outstanding: 134,750,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	100,612,893	141,502,000	71.10%
2025-12-31	114,206,686	136,721,000	83.53%
2025-09-30	110,505,256	137,187,000	80.55%
2025-06-30	111,907,817	136,388,000	82.05%
2025-03-31	109,886,322	134,750,000	81.55%
2024-12-31	110,361,440	124,718,000	88.49%
2024-09-30	109,357,439	123,775,000	88.35%
2024-06-30	113,852,578	122,853,000	92.67%
2024-03-31	110,829,607	120,814,000	91.74%
2023-12-31	108,490,131	114,997,000	94.34%
2023-09-30	106,918,619	115,171,000	92.83%
2023-06-30	100,804,859	113,690,000	88.67%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Natera, Inc. (NTRA) — SEC Financial Statements & Analysis

Natera, Inc. (NTRA) is a services-medical laboratories company, incorporated in DE. Natera, Inc. trades on NTRA: Nasdaq as: NTRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Natera, Inc. reported a 36.59% year-over-year revenue growth, a Gross Profit Margin of 95.39% (TTM), a Debt-to-Equity ratio of 0.47x, a Price-to-Sales (P/S) ratio of 11.32x (TTM), a Price-to-Book (P/B) ratio of 15.95 (TTM), at a market cap of $28.30B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 36.59%
Gross Profit Margin TTM: 95.39%
Debt To Equity: 0.47x
P/S TTM: 11.32x
P/B TTM: 15.95
Market Cap: $28.30B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Natera, Inc. in?

Natera, Inc. (NTRA) operates in the Services-Medical Laboratories industry.

What is NTRA's market cap?

Natera, Inc. (NTRA) has a market capitalization of $28.30B as of 2026-03-31.

What exchange does NTRA trade on?

Natera, Inc. (NTRA) trades on the NTRA: Nasdaq.

Where is Natera, Inc. incorporated?

Natera, Inc. is incorporated in DE.

Natera, Inc. (NTRA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.